Spyridon Fortis1, Edward O Corazalla2, Qi Wang3, Hyun J Kim4. 1. Pulmonary and Critical Care Division, Department of Medicine, University of Minnesota forti042@umn.edu. 2. Pulmonary Function Test Laboratory, University of Minnesota Medical Center. 3. Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota. 4. Pulmonary and Critical Care Division, Department of Medicine, University of Minnesota Pulmonary Function Test Laboratory, University of Minnesota Medical Center.
Abstract
BACKGROUND: Obesity reduces FVC, the most commonly used measurement of vital capacity (VC) and slow VC (SVC). It is unknown whether the difference between SVC and FVC is constant in different body mass indices (BMIs). We hypothesized that the difference between SVC and FVC increases as a function of BMI. METHODS: We retrospectively reviewed pulmonary function tests (PFTs) that included spirometry and plethysmography and were performed in adults from January 2013 to August 2013. A total of 1,805 PFTs were enrolled. The non-parametric Wilcoxon signed-rank test was used to compare FVC with SVC, and to compare FEV1/FVC with FEV1/SVC ratio. Spearman correlation analysis was used to determine whether BMI has an effect on the discordance between FVC and SVC. Finally, we used the McNemar test for paired binary data to compare the prevalence rate of obstruction when using different measurements of VC. RESULTS: In individuals with BMI < 25 kg/m(2) and no evidence of obstruction in the PFTs, FVC was larger than SVC (P = .03), whereas in overweight and obese individuals, SVC was significantly larger than FVC. The difference between SVC and FVC was positively correlated with BMI (P < .001). One hundred thirty-one patients had a normal FEV1/FVC but low FEV1/SVC ratio. Fifty of these 131 individuals also had a normal FVC; the majority of them (46 of 50) had the PFTs for investigation of respiratory symptoms and had BMI > 25 kg/m(2) (42 of 50). CONCLUSIONS: Our results indicate that FVC is larger than SVC in patients with low and normal BMI and no evidence of obstruction in the PFTs, whereas FVC is smaller than SVC in overweight and obese individual. Our findings add to the existing literature that use of FEV1/FVC may lead to underdiagnosis of obstructive airway disease in overweight and obese individuals.
BACKGROUND: Obesity reduces FVC, the most commonly used measurement of vital capacity (VC) and slow VC (SVC). It is unknown whether the difference between SVC and FVC is constant in different body mass indices (BMIs). We hypothesized that the difference between SVC and FVC increases as a function of BMI. METHODS: We retrospectively reviewed pulmonary function tests (PFTs) that included spirometry and plethysmography and were performed in adults from January 2013 to August 2013. A total of 1,805 PFTs were enrolled. The non-parametric Wilcoxon signed-rank test was used to compare FVC with SVC, and to compare FEV1/FVC with FEV1/SVC ratio. Spearman correlation analysis was used to determine whether BMI has an effect on the discordance between FVC and SVC. Finally, we used the McNemar test for paired binary data to compare the prevalence rate of obstruction when using different measurements of VC. RESULTS: In individuals with BMI < 25 kg/m(2) and no evidence of obstruction in the PFTs, FVC was larger than SVC (P = .03), whereas in overweight and obese individuals, SVC was significantly larger than FVC. The difference between SVC and FVC was positively correlated with BMI (P < .001). One hundred thirty-one patients had a normal FEV1/FVC but low FEV1/SVC ratio. Fifty of these 131 individuals also had a normal FVC; the majority of them (46 of 50) had the PFTs for investigation of respiratory symptoms and had BMI > 25 kg/m(2) (42 of 50). CONCLUSIONS: Our results indicate that FVC is larger than SVC in patients with low and normal BMI and no evidence of obstruction in the PFTs, whereas FVC is smaller than SVC in overweight and obese individual. Our findings add to the existing literature that use of FEV1/FVC may lead to underdiagnosis of obstructive airway disease in overweight and obese individuals.
Authors: Daniel Hoesterey; Nilakash Das; Wim Janssens; Russell G Buhr; Fernando J Martinez; Christopher B Cooper; Donald P Tashkin; Igor Barjaktarevic Journal: Respir Med Date: 2019-08-09 Impact factor: 3.415
Authors: Spyridon Fortis; Alejandro P Comellas; Surya P Bhatt; Eric A Hoffman; MeiLan K Han; Nirav R Bhakta; Robert Paine; Bonnie Ronish; Richard E Kanner; Mark Dransfield; Daniel Hoesterey; Russell G Buhr; R Graham Barr; Brett Dolezal; Victor E Ortega; M Bradley Drummond; Mehrdad Arjomandi; Robert J Kaner; Victor Kim; Jeffrey L Curtis; Russell P Bowler; Fernando Martinez; Wassim W Labaki; Christopher B Cooper; Wanda K O'Neal; Gerald Criner; Nadia N Hansel; Jerry A Krishnan; Prescott Woodruff; David Couper; Donald Tashkin; Igor Barjaktarevic Journal: Chest Date: 2021-02-01 Impact factor: 10.262
Authors: Spyridon Fortis; Alejandro Comellas; Victor Kim; Richard Casaburi; John E Hokanson; James D Crapo; Edwin K Silverman; Emily S Wan Journal: Sci Rep Date: 2020-03-20 Impact factor: 4.379
Authors: Namita A Goyal; James D Berry; Anthony Windebank; Nathan P Staff; Nicholas J Maragakis; Leonard H van den Berg; Angela Genge; Robert Miller; Robert H Baloh; Ralph Kern; Yael Gothelf; Chaim Lebovits; Merit Cudkowicz Journal: Muscle Nerve Date: 2020-01-22 Impact factor: 3.217